Johnson & Johnson Innovation

Articles

Paul Tunnah speaks with Patrick Verheyen to hear more about Johnson & Johnson Innovation's approach to partnership.

News

Amgen's Imdelltra and AstraZeneca's Imfinzi have improved survival compared to Imfinzi alone as first-line maintenance treatment for ES-SCLC.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Johnson &amp; Johnson Innovation